Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Drive Implant,Ti,4.3X10: medical device reports filed with FDA

412 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

412
device reports naming the brand
0% of all MAUDE reports · about 65 a year
111
reports, 12 months to August 2026
86 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

412 medical device reports received by FDA name the brand "GM Drive Implant,Ti,4.3X10" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from March 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

111 reports arrived in the 12 months to August 2026, up 29% from 86 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.5%), loss of osseointegration (15.5%) and difficult to insert (1.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01019Sep 2021: 1Oct 2021: 5Nov 2021: 3Dec 2021: 32022Jan 2022: 4Feb 2022: 0Mar 2022: 4Apr 2022: 1May 2022: 3Jun 2022: 1Jul 2022: 4Aug 2022: 5Sep 2022: 6Oct 2022: 7Nov 2022: 12Dec 2022: 92023Jan 2023: 2Feb 2023: 4Mar 2023: 7Apr 2023: 3May 2023: 8Jun 2023: 7Jul 2023: 10Aug 2023: 4Sep 2023: 8Oct 2023: 3Nov 2023: 11Dec 2023: 22024Jan 2024: 6Feb 2024: 2Mar 2024: 2Apr 2024: 10May 2024: 2Jun 2024: 4Jul 2024: 15Aug 2024: 6Sep 2024: 8Oct 2024: 7Nov 2024: 3Dec 2024: 132025Jan 2025: 8Feb 2025: 6Mar 2025: 8Apr 2025: 3May 2025: 0Jun 2025: 19Jul 2025: 8Aug 2025: 3Sep 2025: 9Oct 2025: 7Nov 2025: 8Dec 2025: 62026Jan 2026: 4Feb 2026: 11Mar 2026: 11Apr 2026: 8May 2026: 8Jun 2026: 8Jul 2026: 17Aug 2026: 14

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

043852020: 1220202021: 3120212022: 5620222023: 6920232024: 7820242025: 8520252026: 812026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%412
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report80.8%333
Voluntary report0%0
User facility report0%0
Distributor report19.2%79
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate31175.5%62.8%
Loss of osseointegration6415.5%22.4%
Difficult to insertthe device was hard to insert81.9%0.4%
Fracturea broken bone30.7%1.6%
Separation failure20.5%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis13131.8%
Painpain, site not specified8721.1%
Inflammationinflammation399.5%
Hemorrhage/blood loss/bleeding317.5%
Swelling/ edema317.5%
Fistula163.9%
Hyperresponsive to stimuli112.7%
Abscessa collection of pus92.2%
Tissue damage71.7%
Hypersensitivity/allergic reaction51.2%
Swellingswelling20.5%
Failure of implant10.2%
Inadequate osseointegration10.2%
Numbnessnumbness10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Drive Implant,Ti,4.3X10Product code DZEAll MAUDE reports
Reports4123,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer80.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Drive Implant,Ti,4.3X10 reports

How many FDA reports name GM Drive Implant,Ti,4.3X10?

412 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 111 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.5%), loss of osseointegration (15.5%), difficult to insert (1.9%), fracture (0.7%) and separation failure (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (80.8%) and distributor reports (19.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Drive Implant,Ti,4.3X10 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.